Compliance, attitudes and barriers to post-operative colorectal cancer follow-up

被引:27
作者
Cardella, Jonathan [2 ]
Coburn, Natalie G. [1 ,2 ]
Gagliardi, Anna [1 ,2 ]
Maier, Barbara-Anne [1 ]
Greco, Elisa [1 ]
Last, Linda [1 ]
Smith, Andrew J. [1 ,2 ]
Law, Calvin [1 ,2 ]
Wright, Frances [1 ,2 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Div Gen Surg, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Dept Surg, Toronto, ON, Canada
关键词
attitudes; barriers; colorectal cancer; follow-up; health belief model; survivorship;
D O I
10.1111/j.1365-2753.2007.00880.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Rationale Meta-analyses demonstrate that surveillance following curative-intent colorectal cancer (CRC) surgery can improve survival. Our multidisciplinary team adopted a stringent CRC follow-up (FU) guideline in 2000. The purpose of this study was to assess adherence and barriers to FU for CRC. Methods Patients with primary CRC aged 19-75 years, treated with curative intent surgery from July 2000 to December 2002 were identified from a prospective database. Compliance with FU was assessed primarily by chart review. We also surveyed patients and providers to explore attitudes and barriers to surveillance adherence using tenets of the Health Belief Model. Results 96 patients met inclusion criteria and were appropriate for FU. Median FU was 34 months. Guideline targets were met for 70% of clinic visits; 49% of carcinoembryonic antigen (CEA) determinations; and 62% of abdominal imaging studies. Post-operative colonoscopy did not occur in 6/93 patients. Seventy per cent of health care providers and 55% of patients completed a survey. Access to testing and confusion about which provider orders investigations were identified as important barriers to FU. Conclusion Patterns of CRC FU were widely variable despite implementation of a guideline. Despite patient and provider agreement with the principles of CRC FU, adoption was inhibited by confusion among multiple providers regarding investigation coordination.
引用
收藏
页码:407 / 415
页数:9
相关论文
共 46 条
[1]  
Adam R, 2001, ANN SURG ONCOL, V8, P347
[2]  
[Anonymous], 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002200
[3]  
[Anonymous], 2005, CANC PATIENT CANC SU
[4]   The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer [J].
Chau, I ;
Allen, MJ ;
Cunningham, D ;
Norman, AR ;
Brown, G ;
Ford, HER ;
Tebbutt, N ;
Tait, D ;
Hill, M ;
Ross, PJ ;
Oates, J .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1420-1429
[5]   Improving colorectal cancer follow-up: the dedicated single-visit colorectal cancer follow-up clinic [J].
Cheah, LP ;
Hemingway, DM .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2002, 84 (04) :260-262
[6]  
Chiou ST, 2001, DIABETES RES CLIN PR, V54, pS67
[7]  
Cooper GS, 1999, CANCER-AM CANCER SOC, V85, P2124, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2124::AID-CNCR5>3.0.CO
[8]  
2-L
[10]   Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline [J].
Desch, CE ;
Benson, A ;
Somerfield, MR ;
Flynn, PJ ;
Krause, C ;
Loprinzi, CL ;
Minsky, BD ;
Pfister, DG ;
Virgo, KS ;
Petrelli, NJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) :8512-8519